Experiment 67501

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationZONDER,JA: SHIELDS,AF: ZALUPSKI,M: CHAPLEN,R: HEILBRUN,LK: ARLAUSKAS,P: PHILIP,PA:. (2001). A PHASE II TRIAL OF BRYOSTATIN 1 IN THE TREATMENT OF METASTIC COLORECTAL CANCER.. 7(1)
Amount utilized
Compound isolated
DiseaseA TOTAL OF 28 PATIENTS INCLUDING 16 MEN AND 12 WOMEN (RANGE, 38-76 YEARS); 18 OF PATIENT HAD COLON PRIMARIES, AND THE OTHER 10 HAD RECTAL TUMORS.
Dose amount35.0 MCG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES